Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.

scientific article

Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PROS.21090
P698PubMed publication ID19938014

P50authorKaren AltQ61013891
Philipp WolfQ61089862
P2093author name stringPatrick Bühler
Ursula Elsässer-Beile
Ulrich Wetterauer
Nikolaus Freudenberg
Wolfgang Schultze-Seemann
P2860cites workBiochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigenQ44962359
P433issue5
P921main subjectantibodyQ79460
P304page(s)562-569
P577publication date2010-04-01
P1433published inThe ProstateQ7758608
P1476titleThree conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer
P478volume70

Reverse relations

cites work (P2860)
Q33792596'Image and treat': an individualized approach to urological tumors
Q3445815364Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET.
Q35446801A targeted low molecular weight near-infrared fluorescent probe for prostate cancer
Q36279293Anti-tumor effects of a recombinant anti-prostate specific membrane antigen immunotoxin against prostate cancer cells
Q89779969Comparison of Prostate-Specific Membrane Antigen Expression Levels in Human Salivary Glands to Non-Human Primates and Rodents
Q37591940Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells
Q33827632GCPII imaging and cancer
Q37972920Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer
Q36125199Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging
Q38896408In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer.
Q39198527Metal-Based PSMA Radioligands
Q24634139Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imaging
Q34420372Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.
Q28544848PSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cells
Q41273648PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer
Q98165142PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model
Q36962425Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry
Q36135685Prostate specific membrane antigen- a target for imaging and therapy with radionuclides.
Q36160805Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates
Q41192097Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
Q87193518Prostate-specific membrane antigen as a marker of pancreatic cancer cells
Q38015617Prostate-specific membrane antigen-based imaging
Q38955091Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer
Q38167022Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatment
Q47731005Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives

Search more.